In this study we have examined the localization of interferon-a in liver tissue from acute and chronic hepatitis B virus carriers to establish whether the defect in interferon-a production reported in chronic hepatitis B virus infection is at a pretranscriptional or posttranscriptional level using i
Cellular localization of α-interferon in hepatitis B virus-infected liver tissue
✍ Scribed by Allison R. Jilbert; Professor Christopher J. Burrell; Eric J. Gowans; Paul J. Hertzog; Anthony W. Linnane; Barrie P. Marmion
- Publisher
- John Wiley and Sons
- Year
- 1986
- Tongue
- English
- Weight
- 607 KB
- Volume
- 6
- Category
- Article
- ISSN
- 0270-9139
No coin nor oath required. For personal study only.
✦ Synopsis
Cells expressing a2-interferon were identified by indirect immunofluorescence using both a polyclonal and a monoclonal anti-a-interferon antibody reagent. In hepatitis B or delta virus infection, focal clusters of ainterferon-positive infiltrating mononuclear cells and (to a lesser extent) fibroblasts were regularly seen in liver sections from patients who had chronic active hepatitis and cirrhosis and evidence of virus replication, but in a minority of patients with chronic persistent hepatitis B and not in nonvirally infected livers. This report provides evidence for local a-interferon production near the site of virus replication in hepatitis B infection, identifies mononuclear cells and fibroblasts (but not hepatocytes) as the main cell types producing interferon in this infection and suggests that locally produced a-interferon may be a natural regulator of virus replication in HBsAg-positive chronic active hepatitis. Furthermore, serological characterization of the interferon species produced locally may predict which particular interferon species could be of the greatest therapeutic benefit in specific disease states or individual patients.
Considerable experimental evidence supports the view that interferon (IFN), produced naturally during virus infection, can limit the spread of virus and assist recovery [summarized in (111. In studying specific examples, it is clear that local tissue levels of IFN may vary widely in parallel with levels of virus replication and need not be reflected in serum IFN levels (2). In addition, although many different cell types are capable of producing IFN after in vitro stimulation (3-5), little is known about the cell types expressing IFN in natural disease states.
In at least one published report, serum IFN levels were found to be raised in patients with acute uncomplicated hepatitis A, B or non-A, non-B virus infection (6). In the same study, serum IFN levels were not found to be raised in patients with fulminant hepatitis, and the ability of peripheral mononuclear cells to produce IFN in vitro after stimulation in these subjects was markedly de-
📜 SIMILAR VOLUMES
Interferon-a elicits antiviral and immunoregulatory activities by binding to specific receptors on the cell surface. In this study, binding characteristics of interferon-a to peripheral blood mononuclear cells in patients with chronic hepatitis B virus infection were studied using radioiodinated rec
Orthotopic liver transplantation in patients with hepatitis B-related cirrhosis is commonly complicated by reinfection with the hepatitis B virus, with rapidly progressive liver disease and poor survival rate. We assessed the efficacy of prior therapy with recombinant interferon-a on the prevention
Hepatitis B virus (HBV) core gene translational products were localised previously in the cytoplasm and/or in the nuclei of infected cells. We investigated in naturally infected human hepatocytes whether this variation in the subcellular expression is due to differences in the presence of assembled